awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26773653-035F05FB-DF97-46AA-B640-710C82139B2F
Q26773653-035F05FB-DF97-46AA-B640-710C82139B2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26773653-035F05FB-DF97-46AA-B640-710C82139B2F
Sequence of treatment in locally advanced and metastatic renal cell carcinoma
P2860
Q26773653-035F05FB-DF97-46AA-B640-710C82139B2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26773653-035F05FB-DF97-46AA-B640-710C82139B2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92ac32939b7e1b88cbe02fbe2fce0005df03a3ea
P2860
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.